What Did the Research Discover? The research demonstrated that a 10-month quality improvement initiative significantly increased the number of Hepatitis C Virus (HCV) RNA-positive patients who initiated curative treatment in a primary care setting. The proportion of patients who started treatment rose from 66.0% to 75.5%, and of those who initiated treatment, an...
Can medications for type 2 diabetes also protect the brain? A new meta-analysis published in Movement Disorders Clinical Practice combined results from 24 clinical trials—and found a possible link between newer diabetes medications and a lower risk of Parkinson’s disease.
What Did the Research Discover? This study explored the relationship between chronotype (morning vs. evening preference) and the risk of developing type 2 diabetes in middle-aged nurses. The findings suggest that nurses with an evening chronotype—those who naturally stay up late and wake up later—are more likely to have unhealthy lifestyle habits and a higher risk...
Before any new medicine can be sold, it must go through several steps of testing called clinical trials. These studies help doctors and scientists learn whether a drug is safe, whether it works, and what side effects it might cause. What Is a Phase 1 Clinical Trial? Phase 1 is the first time a new drug is tested in people. These studies are small—usually involving a...
What Did the Research Discover? This study investigated whether lifestyle interventions (LI) for preventing type 2 diabetes are equally effective for all individuals with prediabetes or if different approaches are needed based on individual risk levels. The researchers categorized participants into low-risk (LR) and high-risk (HR) phenotypes based on factors such as...
Do your natural sleep habits affect your risk of type 2 diabetes? A 2023 study published in Annals of Internal Medicine followed over 63,000 middle-aged nurses to explore whether being a night owl or morning person impacts diabetes risk—even after accounting for diet, weight, and lifestyle.